Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer
NCT01612871
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Tamoxifen, Letrozole , Anastrozole, Exemestane
Sponsor
Institut Claudius Regaud